HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Herrmann Selected Research

Combined Modality Therapy

1/2018CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
3/2009Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.
11/2008The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.
1/2008The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Herrmann Research Topics

Disease

172Neoplasms (Cancer)
03/2024 - 07/2005
122Prostatic Neoplasms (Prostate Cancer)
05/2024 - 08/2008
49Neoplasm Metastasis (Metastasis)
03/2024 - 01/2011
24Breast Neoplasms (Breast Cancer)
02/2024 - 12/2010
20Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2024 - 01/2014
19Thyroid Neoplasms (Thyroid Cancer)
12/2023 - 01/2015
15Sarcoma (Soft Tissue Sarcoma)
05/2024 - 04/2012
15Lymphoma (Lymphomas)
02/2024 - 11/2008
14Adenocarcinoma
12/2023 - 10/2006
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2023 - 11/2011
11Glioblastoma (Glioblastoma Multiforme)
07/2023 - 09/2006
9Lung Neoplasms (Lung Cancer)
04/2024 - 01/2020
9Hepatocellular Carcinoma (Hepatoma)
12/2023 - 09/2009
9Stomach Neoplasms (Stomach Cancer)
01/2014 - 12/2007
7Glioma (Gliomas)
12/2023 - 10/2014
6Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 09/2008
5Carcinoma (Carcinomatosis)
12/2023 - 02/2009
5Thyroid Diseases (Thyroid Disease)
12/2022 - 01/2019
5Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2021 - 06/2007
5Multiple Myeloma
01/2017 - 09/2014
4Infections
03/2024 - 08/2020
4Amyloidosis
01/2024 - 01/2023
4Cardiotoxicity
11/2023 - 01/2022
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2023 - 02/2016
4Thyroid Nodule (Nodule, Thyroid)
04/2023 - 03/2021
4Fibrosis (Cirrhosis)
01/2023 - 04/2008
4Pain (Aches)
01/2023 - 11/2019
4Rectal Neoplasms (Rectal Cancer)
09/2020 - 02/2009
3Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2024 - 01/2018
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 05/2011
3Brain Neoplasms (Brain Tumor)
12/2023 - 04/2016
3Lymphatic Metastasis
12/2023 - 10/2023
3Inflammation (Inflammations)
11/2023 - 01/2019
3Malignant Mesothelioma
03/2023 - 11/2017
3COVID-19
01/2023 - 08/2020
3Pheochromocytoma
01/2023 - 01/2021
3Fabry Disease (Fabry's Disease)
02/2022 - 01/2020
3Melanoma (Melanoma, Malignant)
02/2022 - 02/2019
3Margins of Excision
01/2022 - 10/2020
3Residual Neoplasm
01/2019 - 04/2008
3Parkinson Disease (Parkinson's Disease)
01/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

70AntigensIBA
04/2024 - 06/2015
68Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2024 - 10/2006
23Proteins (Proteins, Gene)FDA Link
05/2024 - 12/2008
23Glucose (Dextrose)FDA LinkGeneric
03/2023 - 10/2006
22gallium 68 PSMA-11IBA
12/2023 - 06/2015
22LigandsIBA
02/2023 - 01/2015
19Somatostatin Receptors (Somatostatin Receptor)IBA
11/2023 - 04/2014
19Biomarkers (Surrogate Marker)IBA
07/2023 - 12/2008
17Radioisotopes (Radionuclides)IBA
11/2023 - 01/2014
12Chemokine ReceptorsIBA
03/2023 - 04/2015
11RadiopharmaceuticalsIBA
05/2024 - 01/2011
11Peptide Receptors (Peptide Receptor)IBA
04/2024 - 01/2014
11Choline (Choline Chloride)IBA
10/2021 - 08/2008
10Prostate-Specific Antigen (Semenogelase)IBA
04/2024 - 07/2005
10177Lu-PSMA-617IBA
01/2024 - 11/2017
9Hormones (Hormone)IBA
01/2024 - 01/2021
868Ga-FAPIIBA
05/2024 - 01/2023
8Edotreotide (SMT 487)IBA
11/2023 - 01/2011
868Ga-pentixaforIBA
11/2017 - 01/2015
7IodineIBA
01/2023 - 04/2015
7ThymidineIBA
01/2014 - 05/2008
6Androgen Receptors (Androgen Receptor)IBA
04/2024 - 10/2018
6Yttrium-90IBA
12/2023 - 11/2019
5Lutetium-177IBA
04/2024 - 01/2018
5Immune Checkpoint InhibitorsIBA
11/2023 - 01/2021
5AndrogensIBA
01/2023 - 10/2010
5alovudineIBA
01/2022 - 12/2007
5Amino AcidsFDA Link
06/2019 - 07/2010
4Rituximab (Mabthera)FDA Link
12/2022 - 06/2007
4Ga(III)-DOTATOCIBA
01/2022 - 04/2020
4Fluorine-18IBA
10/2021 - 04/2008
4Methionine (L-Methionine)FDA Link
06/2019 - 09/2009
4gallium Ga 68 dotatateIBA
11/2017 - 01/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 06/2007
3ErbB Receptors (EGF Receptor)IBA
04/2024 - 11/2011
3Prealbumin (Transthyretin)IBA
01/2024 - 01/2019
3Amyloid (Amyloid Fibrils)IBA
01/2024 - 01/2022
3FAPI-46IBA
01/2024 - 10/2022
3Peptides (Polypeptides)IBA
05/2023 - 11/2016
3ThyroglobulinFDA Link
02/2023 - 04/2021
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2023 - 04/2014
3taxaneIBA
01/2023 - 10/2010
3Deoxyglucose (2 Deoxy D glucose)IBA
02/2022 - 07/2005
3Gallium-68IBA
01/2021 - 01/2018
3Anaplastic Lymphoma KinaseIBA
01/2018 - 10/2012

Therapy/Procedure

168Therapeutics
05/2024 - 10/2006
45Castration
05/2024 - 07/2014
36Drug Therapy (Chemotherapy)
04/2024 - 10/2006
32Radiotherapy
04/2024 - 02/2016
22Precision Medicine
05/2024 - 01/2017
16Neoadjuvant Therapy
10/2023 - 09/2007
11Prostatectomy (Retropubic Prostatectomy)
12/2023 - 07/2005
10Immunotherapy
11/2023 - 06/2007
10Chemoradiotherapy
05/2023 - 04/2008
6Lymph Node Excision (Lymph Node Dissection)
04/2024 - 01/2017
6Microspheres (Microsphere)
12/2023 - 12/2019
4Thyroidectomy
12/2023 - 09/2009
4Induction Chemotherapy
09/2022 - 01/2008
4Combined Modality Therapy
01/2018 - 01/2008